Search

The immediate treatment of patients with anaphylaxis is held to be adequate, yet major deficiencies remain in their further diagnostic evaluation, in the prescribing of emergency medications, and in patient education” Ring et al (2018).

Abstract;

BACKGROUND: Anaphylaxis is the most serious manifestation of an immediate allergic reaction and the most common emergency event in allergology. Adrenaline (epi- nephrine) is the mainstay of acute pharmacotherapy for this complication. Although epinephrine has been in use for more than a century, physicians and patients are often unsure and inadequately informed about its proper administration and dosing in everyday situations.

METHODS: This review is based on pertinent publications from the period 1 January 2012 to 30 September 2017 that were retrieved, on the basis of the existing guide- lines of 2007 and 2014, by a PubMed search employing the keywords “anaphylaxis treatment,” “allergic shock,” “adrenaline,” and “epinephrine,” as well as on further ar- ticles from the literature.

RESULTS: Adrenaline/epinephrine administration often eliminates all manifestations of anaphylaxis. The method of choice for administering it (except in intensive-care medicine) is by intramuscular injection with an autoinjector; this is mainly done to treat reactions of intermediate severity. The injection is given in the lateral portion of the thigh and can be repeated every 10-15 minutes until there is a response. The dose to be administered is 300-600 µg for an adult or 10 µg/kg for a child. The risk of a serious cardiac adverse effect is lower than with intravenous administration. There have not been any randomized controlled trials on the clinical efficacy of ephi- nephrine in emergency situations. The use of an autoinjector should be specially practiced in advance.

CONCLUSION: The immediate treatment of patients with anaphylaxis is held to be adequate, yet major deficiencies remain in their further diagnostic evaluation, in the prescribing of emergency medications, and in patient education. Further research is needed on cardiovascular involvement in anaphylaxis and on potential new thera- peutic approaches.

You may also be interested in…

[rp4wp]
[button link=”https://www.aerzteblatt.de/int/archive/article?id=199289″ color=”default”]Full Story[/button]
[spacer height=”20px”]



Reference:

Ring, J., Klimek, L. and Worm, M. (2018) Adrenaline in the Acute Treatment of Anaphylaxis. Deutsches Ärzteblatt International. 115(31-32), P.528-534.

doi: 10.3238/arztebl.2018.0528.